Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

EFAI RTSUITE CT HCAP-Segmentation System

K-Number: K231928 · 2023-09-25

Decision Date2023-09-25
Product CodeQKB
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

EFAI RTSUITE CT HCAP-Segmentation System is a medical device manufactured by Ever Fortune.Ai, Co., Ltd.. It received FDA 510(k) clearance on 2023-09-25 under approval number K231928. The device is classified under product code QKB. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the EFAI RTSUITE CT HCAP-Segmentation System?

EFAI RTSUITE CT HCAP-Segmentation System is a medical device that received FDA 510(k) clearance on 2023-09-25. It is manufactured by Ever Fortune.Ai, Co., Ltd.. The 510(k) number is K231928.

When was EFAI RTSUITE CT HCAP-Segmentation System approved by the FDA?

EFAI RTSUITE CT HCAP-Segmentation System received FDA 510(k) clearance on 2023-09-25, under approval number K231928.

What company makes EFAI RTSUITE CT HCAP-Segmentation System?

EFAI RTSUITE CT HCAP-Segmentation System is manufactured by Ever Fortune.Ai, Co., Ltd..

What is the FDA product code for EFAI RTSUITE CT HCAP-Segmentation System?

The FDA product code for EFAI RTSUITE CT HCAP-Segmentation System is QKB.

Other Devices by Ever Fortune.Ai, Co., Ltd.

View all 15 devices →

Related Devices (Code: QKB)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.